Cleared Traditional

K810296 - DIGOXIN RIA ASSAY

K810296 is the FDA 510(k) clearance for DIGOXIN RIA ASSAY by Ria Diagnostics. It is a Class 2 Toxicology device (product code DON) cleared through the Traditional 510(k) pathway after a 15-day FDA review.

K810296 · Ria Diagnostics · Toxicology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1981
Decision
15d
Days
Class 2
Risk

K810296 is an FDA 510(k) clearance for the DIGOXIN RIA ASSAY. Classified as Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Solid Phase Sep. (product code DON), Class II - Special Controls.

Submitted by Ria Diagnostics (Mchenry, US). The FDA issued a Cleared decision on February 19, 1981 after a review of 15 days - a notably fast clearance cycle.

This device falls under the Toxicology FDA review panel, regulated under 21 CFR 862.3320 - the FDA toxicology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Ria Diagnostics devices

Submission Details

510(k) Number K810296 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 04, 1981
Decision Date February 19, 1981
Days to Decision 15 days
Submission Type Traditional
Review Panel Toxicology (TX)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
72d faster than avg
Panel avg: 87d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DON Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Solid Phase Sep.
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.3320
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Toxicology devices follow this clearance model.

Regulatory Peers - DON Radioimmunoassay, Digoxin (125-i), Rabbit Antibody, Solid Phase Sep.

All 11
Devices cleared under the same product code (DON) and FDA review panel - the closest regulatory comparables to K810296.
CIBA CORNING MAGIC LITE DIGOXIN IMMUNOASSAY
K881679 · Ciba Corning Diagnostics Corp. · Jul 1988
MAGIC 125I DIGOXIN RADIOIMMUNOASSAY
K840461 · Corning Medical & Scientific · Mar 1984
ENZYMUNE-TEST DIGOXIN
K821000 · Icl Scientific · Apr 1982
DIGOXIN RIABEAD DIAGNOSTIC KIT
K803075 · Abbott Laboratories · Dec 1980
TECHNICON STAR SYSTEM
K791549 · Technicon Instruments Corp. · Sep 1979
RIA, DIGOXIN
K781660 · E. R. Squibb & Sons, Inc. · Oct 1978